Evidence map›Paper›PMID 12937127›Full record

ArticleThe American journal of pathology2003

Significance of immunological detection of human telomerase reverse transcriptase: re-evaluation of expression and localization of human telomerase reverse transcriptase.

Satoru Kyo, Kenkichi Masutomi, Yoshiko Maida, Taro Kanaya, Noriyuki Yatabe, Mitsuhiro Nakamura, Masaaki Tanaka, Mitsuko Takarada, Isamu Sugawara, Seishi Murakami and 2 more

Open access · greenAbstract read
In one paragraph

Article in The American journal of pathology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Endometrial stem cells in regenerative medicine.Journal of biological engineering · 2014
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Telomerase downregulation in cancer brain stem cell.Molecular and cellular biochemistry · 2009
    Article
  16. Immunohistochemical expression of ubiquitin and telomerase in cervical cancer.Virchows Archiv : an international journal of pathology · 2009
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Satoru KyoDepartment of Obstetrics and Gynecology, School of Medicine, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8641, Japan. satoruky@med.kanazawa-u.ac.jp
Kenkichi Masutomi
Yoshiko Maida
Taro Kanaya
Noriyuki Yatabe
Mitsuhiro Nakamura
Masaaki Tanaka
Mitsuko Takarada
Isamu Sugawara
Seishi Murakami
Takahiro Taira
Masaki Inoue
Kanazawa University · JPHokkaido University · JPJapan Anti Tuberculosis Association · JPKyowa Chemical Industry (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human telomerase reverse transcriptase (hTERT) is a catalytic subunit of telomerase and is a potentially useful diagnostic marker for cancers. There have been few studies in which immunological detection of hTERT has been attempted and its subcellular localization has not been precisely defined. In the present study, we re-evaluated expression and localization of hTERT in cancer and normal cells using a newly developed antibody. Immunohistochemistry revealed that hTERT is expressed in approximately 80% of gynecological cancers, but some premalignant lesions exhibited weak expression of hTERT. Interestingly, not only nuclei but also cytoplasm of cancer cells were positive for hTERT staining. This finding was supported by the results of Western blot analysis of cell lines, in which both nuclear and cytoplasmic extracts exhibited significant hTERT bands. Cytoplasmic hTERT in cancer cells may be functional because the telomeric repeat amplification protocol assay of cytoplasmic extracts showed high levels of telomerase activity. Unexpectedly, not all normal primary cells and telomerase-negative cancer cell lines lacked hTERT expression; some exhibited weak TERT signals. In Western analysis, hTERT signals did not always correlate with telomerase activity of the various cell types. These findings suggest that functional hTERT is expressed in both the nucleus and cytoplasm of cancer cells and that hTERT expression does not strictly reflect telomerase activity. Further analysis is needed to clarify the biological significance of cytoplasmic hTERT.

Indexed as

Blotting, WesternCell NucleusCytoplasmDNA-Binding ProteinsFemaleGenital Neoplasms, FemaleHumansImmunohistochemistrySubcellular FractionsTelomeraseTissue DistributionTumor Cells, CulturedDNA-Binding ProteinsTelomeraseTERT protein, human

Identifiers

PMID12937127
PMCPMC1868244
OpenAlexW1584294981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.